Prognostic significance of blood coagulation tests in lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 231s Year: 2001
Prognostic significance of blood coagulation tests in lung cancer Source: Eur Respir J 2001; 17: 667-673 Year: 2001
The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006
Small cell lung cancer: prognostic significance and correlation with clinical and laboratory parameters Source: Eur Respir J 2007; 30: Suppl. 51, 670s Year: 2007
What is the evidence so far: cytology and blood tests Source: Annual Congress 2005 - A sceptical look at lung cancer screening Year: 2005
Combining exhaled-breath analysis data with clinical parameters to improve the diagnosis of lung cancer Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019
The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002
Lung function testing for the preoperative evaluation of patients with lung cancer Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003
Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker of small cell lung cancer? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
RARβ2 methylation level in blood for lung cancer assessment Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
Our diagnostic time for lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 322s Year: 2005
Features of an estimation of the functional condition of patients with complicated lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 11s Year: 2004
The diagnostic value of serum tumor markers in newly diagnosed lung cancer patients Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
What is real prevalence of COPD in patients with lung cancer? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008
Analyses of prognostic factors in patients undergoing surgery for lung cancer. Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019
Possible predictors of the bronchodilation test response within lung function assessment of patients with operable lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005
Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013
Analysis of surgical stage lung cancer and tumour markers prognostic value Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006